Menopause, Hormone Therapy, and Alzheimer’s: Why HRT Timing Matters

As women age, levels of the sex hormone estrogen start to drop, leading to menopause. Menopause signals more than the end of monthly periods: It brings disruptive symptoms like hot flashes, bladder weakness, joint pain, and cognitive impairment, often referred to as “menopause brain.” 

Since estrogen is involved in helping brain cells communicate and regulating inflammation, scientists speculated that the drop in estrogen could contribute to Alzheimer’s and cognitive decline. Menopause could help explain why women are twice as likely as men to develop the disease. About five percent of American women opt for hormone replacement therapy — a pill or patch form of therapy to compensate for the hormones lost during menopause. HRT contains natural or synthetic versions of estrogen or sometimes in combination with another hormone called progesterone. But does HRT affect Alzheimer’s risk?

A new study presented at the American Neurological Association’s 2025 conference in Baltimore investigated how the timing of HRT affected Alzheimer’s risk. Study author Dr. Fnu Vaibhav of the Pandit Bhagwat Dayal Sharma University in India conducted a meta-analysis examining more than 50 studies. 

Taking HRT within five to 10 years of when menopause starts lowers Alzheimer’s risk, while starting it after age 65 increases it. “The evidence isn’t strong enough to suggest hormone replacement therapy should be taken to prevent Alzheimer’s,” Vaibhav said in a press release. 

How does hormone therapy impact Alzheimer’s risk?

Gold-standard trials, which randomize participants to receive either a treatment like HRT or placebo, while making sure neither the participants nor the researchers know who is part of what group, provided some evidence that taking HRT at 65 or older increased Alzheimer’s risk 38 percent. The risk was highest for those taking a form of HRT called progestin, a synthetic version of the sex hormone progesterone. 

Vaibhav speculated that the clotting properties of the sex hormones in these treatments, like estrogen and progesterone, might cause trouble later in life — damaging the brain’s blood vessels and impairing the flow of oxygen and nutrients.

Studies of electronic health records that compared women who took HRT to those who didn’t found that treatment within a few years of starting menopause lowered Alzheimer’s risk by 22 percent. Initiating HRT within five years of starting menopause offered the most protection, reducing the risk by 32 percent. 

The benefits might be explained by the broad neuroprotective effects of estrogen. Like many other hormones or neurochemicals, estrogen and progesterone play many different roles in the body and brain depending on context. 

However, observational studies do not control for confounding factors that might influence these results. For instance, women who are more likely to seek out HRT, on average, are healthier, wealthier, and have more access to doctors, which might explain why they have a lower risk.

When accounting for the quality of the research studies, Vaibhav saw more modest effects of HRT across higher-quality studies, where the methods are more robust and there is less chance of influencing the results. 

Does the study change how we treat menopause or prevent Alzheimer’s?

Dr. Beau Ances, a neurologist at Washington University in St. Louis, who wasn’t involved in the research, told Being Patient that while the findings were useful, when it comes to finding the ideal timing for HRT, “the field is still trying to figure it all out.” 

The study’s findings are in line with previous research. 

“This is a summary of pre-existing data that includes studies of different designs, different durations and various sizes, some observational and some clinical trials,” Dr. Susan Davis, an endocrinologist and professor at Monash University, told Being Patient. Davis, who specializes in studying sex hormones and wasn’t involved in the research, added, “There are no new findings in this review.” 

The conclusions are also in line with the 2022 position statement of the North American Menopause Society guidelines. They state that HRT has the most benefit for treating menopause symptoms and preventing bone loss in women 60 or younger and those within ten years of menopause onset. The guidelines also note that starting HRT later may increase the risk of heart disease, stroke, and dementia.

Arce said that new clinical trials are needed to know for sure whether HRT can prevent Alzheimer’s and when to start and stop treatment. 

The takeaway for now?  “Do not recommend HRT for Alzheimer’s disease prevention or treatment,” Vaibhav told Being Patient. “Instead, use it for menopause symptoms, tailored by age and individual risks.”

FAQs about hormone replacement therapy, menopause, and Alzheimer’s

Can hormone replacement therapy prevent Alzheimer’s?

Right now, experts say no. Doctors do not recommend HRT as an Alzheimer’s prevention strategy. Some studies show that starting HRT soon after menopause may support brain health and lower dementia risk, but the evidence isn’t strong enough to use it for prevention. Today, HRT is prescribed mainly to treat menopause symptoms.

When is the best time to start hormone replacement therapy?

Timing is important. Research suggests HRT is most beneficial when started within 5 to 10 years of menopause onset, especially before age 60. This early window may support menopause-related brain health and lower Alzheimer’s risk. Starting HRT later, after age 65, is linked to higher risks.

Does HRT increase dementia risk after age 65?

Yes. Studies on HRT timing and Alzheimer’s risk show that beginning hormone therapy later in life — particularly after age 65 — may increase dementia risk by up to 38 percent, depending on the type of hormone used.

Why does timing of HRT matter for menopause and brain health?

Estrogen and progesterone play key roles in brain health by regulating inflammation, blood flow, and communication between brain cells. Early in menopause, HRT may protect against cognitive decline. But later in life, these hormones may contribute to clotting or blood vessel damage, raising Alzheimer’s and dementia risk.

What should women consider before starting HRT?

Doctors recommend weighing personal health history, age, and severity of menopause symptoms. HRT can help with hot flashes, bone loss, and sleep problems. However, when it comes to menopause and Alzheimer’s, experts stress that HRT should not be used solely for brain health or dementia prevention.